{"id":67003,"date":"2025-04-24T12:01:50","date_gmt":"2025-04-24T12:01:50","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/04\/24\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/"},"modified":"2025-04-24T12:01:50","modified_gmt":"2025-04-24T12:01:50","slug":"nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/","title":{"rendered":"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the  2025 Robert W. Berliner Award for Excellence in Renal Physiology"},"content":{"rendered":"<div>\n<p align=\"justify\"><b>April 25, 2025,<\/b> <b>Seattle, WA<\/b> \u2013 NephroDI Therapeutics (NephroDI), a pharmaceutical company focusing on kidney disorders, announces that its Founder and CMO, Jeff M. Sands, M.D., is the recipient of the 2025 Robert W. Berliner Award for Excellence in Renal Physiology. This is the most prestigious award of the American Physiological Society Renal Section and is given in recognition of a distinguished lifetime achievement in advancing renal physiological research.<\/p>\n<p align=\"justify\"><b>Dr. Sands, NephroDI Founder and CMO,<\/b> said: \u201cI am deeply honored to receive this award from the American Physiological Society. This award is not just a recognition of my individual contribution, but a testament to the collective effort and passion of all the colleagues who have worked with me. This work has led me to be one of the Founders of NephroDI, where we share a common goal to develop therapeutic options for patients suffering with the rare kidney disease, congenital Nephrogenic Diabetes Insipidus (NDI). It is my hope that this lifetime of work will now be translated into a novel therapy with the potential to benefit the lives of children suffering from this life-altering condition. I would like to thank the American Physiological Society for this recognition as we strive to transform the lives of NDI patients.\u201d<\/p>\n<p align=\"justify\"><b>Rachael Hagan, CEO of NephroDI, <\/b>added: \u201cWe are truly fortunate at NephroDI to have world-class scientific Founders. Jeff is an inspiration to us all, displaying a strong desire not only to contribute to the advancement of science, but also for translating these learnings into real benefits for patients. His lifetime\u2019s work is a testament to his perseverance and dedication, and at NephroDI we look forward to continuing our work together on behalf of the entire NDI community.\u201d <\/p>\n<p align=\"justify\">Dr. Sands\u2019 research focuses on understanding the molecular physiology underlying congenital Nephrogenic Diabetes Insipidus (NDI) and the translation of these basic research findings into novel therapies. Congenital NDI is a rare X-linked genetic condition that affects individuals from birth, in which they produce significant amounts of dilute urine daily because their kidneys lack the ability to concentrate urine. In addition to the clinical problems caused by this disease, it can have a significant impact on quality of life. <\/p>\n<p align=\"justify\">Dr. Sands is the Juha P. Kokko Professor Emeritus of Medicine at Emory University (Atlanta, GA) and has authored over 180 peer-reviewed manuscripts during his distinguished career. He served as Editor-in-Chief of the <i>American Journal of Physiology \u2013 Renal<\/i> from 2001-2007 and as President of the American Physiological Society from 2018-2019. He is a member of the American Association of Physicians and the American Society for Clinical Investigation.<\/p>\n<p align=\"justify\">During his career, Dr. Sands has received several honors, including: the Carl Gottschalk Distinguished Lecturer for the American Physiological Society Renal Section in 2013; the Distinguished Achievement Award from the American Heart Association in 2014; and the Homer W. Smith Award from the American Society of Nephrology in 2022. He was awarded the honorary degree of Doctor Medicinae Honoris Causa from Aarhus University in Denmark in 2018.\u00a0 <\/p>\n<p align=\"justify\">Dr. Sands is a graduate of Harvard College and Boston University School of Medicine.\u00a0 <\/p>\n<p align=\"justify\"><b>About NephroDI Therapeutics <\/b><\/p>\n<p align=\"justify\">NephroDI Therapeutics, Inc. is a pharmaceutical company headquartered in Seattle, WA, focused on developing and commercializing drugs to treat concentration disorders of the kidney. The company\u2019s lead program is NDI-5001, a novel kidney-targeted small molecule AMPK activator being developed as a potential first-in-class treatment of Congenital Nephrogenic Diabetes Insipidus. For more information, please visit the company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hzatRcTNmuToPrOOOp2EEolDJYlY-Lxo0xW3HWS54wqpXMRrj8ZwaiAVq-SoC3aAgw_XJscsKwgj7pYS8xj9AkR6ODT-w12bj8ccvBsHc40=\" rel=\"nofollow\" target=\"_blank\" title=\"www.nephrodi.com\">www.nephrodi.com<\/a>.<\/p>\n<p align=\"justify\">NephroDI Media Contact:<\/p>\n<p align=\"justify\">Josh Knackert<\/p>\n<p align=\"justify\"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dBpqTkLzeKj_Cc8xOE0QgDAGTsrE1TKTSocGsP2ib0Y9raceO5d3mq7tTJN_jumytP6kPiK7nhTBiNqBDWdF7n9TCdHhoSPnhBVpJj1Jp-aeBwB1TZeC97NlnI0694jW\" rel=\"nofollow\" target=\"_blank\" title=\"jknackert@nephrodi.com\">jknackert@nephrodi.com<\/a><\/p>\n<p align=\"justify\">MEDiSTRAVA<\/p>\n<p align=\"justify\">Frazer Hall\/Mark Swallow<\/p>\n<p align=\"justify\"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m3LGk8JebE9IRsnpJo1uXT2YbtxTqhwZk_N7aGsdHIjaTTNOWPjNOAYxtTlgVTDX7yibhRoZWwHWNSdXrnU-DuWJpGNrwmED7guxwkG0vIbuvbbtQVsPxgOEQ_dCu8if\" rel=\"nofollow\" target=\"_blank\" title=\"NephroDI@medistrava.com\">NephroDI@medistrava.com<\/a><\/p>\n<p align=\"justify\"><b>Forward-looking Statements<\/b><\/p>\n<p align=\"justify\">This press release contains certain \u201cforward-looking statements\u201d concerning the development of NephroDI Therapeutics\u2019 products, the potential benefits and attributes of those products, and the company\u2019s expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions, and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. NephroDI Therapeutics undertakes no obligation to update any forward-looking statements for any reason.<\/p>\n<p>Press Release URL: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GBzmkStj5ZHhhg5TrVAmZrdxcmi5UDIFUPw9gLR4vveL5t0VR9Kfz99KibXvjRuSMAULcvF8Du97SAubK23yQuweEnETwFu1wAxOROn5EaZnpJUYyRe2GPFSiXVyjRd4\" rel=\"nofollow\" target=\"_blank\" title=\"News | NephroDI Therapeutics\">News | NephroDI Therapeutics<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NTgxZjU3MjQtMDY4ZS00OWNlLWI4ZjctYTQ4ODVmYjRjY2EzLTcwMDAyNDcxOS0yMDI1LTA0LTI0LWVu\/tiny\/NephroDI-Therapeutics.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>April 25, 2025, Seattle, WA \u2013 NephroDI Therapeutics (NephroDI), a pharmaceutical company focusing on kidney disorders, announces that its Founder and CMO, Jeff M. Sands, M.D., is the recipient of the 2025 Robert W. Berliner Award for Excellence in Renal Physiology. This is the most prestigious award of the American Physiological Society Renal Section and [&#8230;]\n","protected":false},"author":1,"featured_media":67004,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-67003","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology\" \/>\n<meta property=\"og:description\" content=\"April 25, 2025, Seattle, WA \u2013 NephroDI Therapeutics (NephroDI), a pharmaceutical company focusing on kidney disorders, announces that its Founder an\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-24T12:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/04\/NephroDI-Therapeutics.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology\",\"datePublished\":\"2025-04-24T12:01:50+00:00\",\"dateModified\":\"2025-04-24T12:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/\"},\"wordCount\":695,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/\",\"name\":\"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-04-24T12:01:50+00:00\",\"dateModified\":\"2025-04-24T12:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/","og_locale":"en_US","og_type":"article","og_title":"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology","og_description":"April 25, 2025, Seattle, WA \u2013 NephroDI Therapeutics (NephroDI), a pharmaceutical company focusing on kidney disorders, announces that its Founder an","og_url":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-04-24T12:01:50+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/04\/NephroDI-Therapeutics.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology","datePublished":"2025-04-24T12:01:50+00:00","dateModified":"2025-04-24T12:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/"},"wordCount":695,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/","url":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/","name":"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-04-24T12:01:50+00:00","dateModified":"2025-04-24T12:01:50+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/nephrodi-therapeutics-founder-and-cmo-jeff-m-sands-m-d-receives-the-2025-robert-w-berliner-award-for-excellence-in-renal-physiology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"NephroDI Therapeutics\u2019 Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/67003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=67003"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/67003\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/67004"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=67003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=67003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=67003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}